Maximus (MMS) AI Stock Analysis

• Market Cap: $3.93B
• Dividend Yield: 1.72%
• Average Volume (3M): 429.53K
• Price to Earnings (P/E): 13.9
• Beta (1Y): 0.41
• Revenue Growth: 5.29%
• EPS Growth: 31.95%
• Country: US
• Employees: 41,100
• Sector: Industrials
• Sector Strength: 87
• Industry: Specialty Business Services
• EPS (TTM): 2.01
• Shares Outstanding: 56,349,400
• 10 Day Avg. Volume: 386,774
• 30 Day Avg. Volume: 429,526
• PEG Ratio: -0.59
• Price to Book (P/B): 2.31
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 15.30
• Enterprise Value/Market Cap: 1.28
• Enterprise Value/Revenue: 0.24
• Enterprise Value/Gross Profit: 3.96
• Enterprise Value/Ebitda: 2.15
• 1Y Price Target: $90.00
• Price Target Upside: 28.94% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 81 Outperform
• Price Target: $83.00 ▲(18.91%Upside)

Maximus scores well overall, driven by strong financial performance and a positive earnings call highlighting growth and innovation. The valuation remains attractive with a reasonable P/E ratio and dividend yield. Technical indicators show neutral momentum, which is consistent with its current market position. The company should focus on managing leverage and improving cash flow to maintain its competitive edge.

Maximus Business Overview & Revenue Model

Company Description

Maximus, Inc. (MMS) is a leading provider of government services worldwide, primarily focusing on health and human services programs. The company operates in three main segments: U.S. Services, U.S. Federal Services, and Outside the U.S. Maximus partners with government agencies to deliver essential services, including program management, business process outsourcing, and consulting services, to help improve public program efficiency and effectiveness.

How the Company Makes Money

Maximus generates revenue by securing contracts with government agencies to deliver a wide range of services. The company's revenue model is primarily based on long-term contracts that involve managing and operating government health and human services programs. These contracts often include performance-based incentives, where Maximus earns additional revenue by meeting or exceeding certain service benchmarks. Significant revenue streams include providing administrative support for Medicaid and Medicare, as well as managing welfare-to-work programs and other social services. Key factors contributing to its earnings include the company's expertise in navigating complex government regulations, its ability to streamline and modernize service delivery, and its strategic partnerships with technology and consulting firms to enhance service offerings.

Maximus Financial Statement Overview

Summary

Maximus demonstrates strong revenue growth and maintains healthy profit margins, indicating robust operational performance. The balance sheet shows increased leverage, which could be a risk if not managed, but equity remains strong. Cash flow generation is positive but declining, indicating a need for careful cash management. Overall, the company is financially sound but should focus on managing leverage and enhancing cash flow.

Income Statement

Maximus shows strong revenue growth with a 16.9% increase from 2023 to TTM (Trailing-Twelve-Months), indicating robust business expansion. The gross profit margin remains solid at 23.6% for TTM, reflecting efficient cost management. However, net profit margin slightly decreased to 5.6%, suggesting some pressure on net earnings. EBIT and EBITDA margins are healthy at 9.1% and 10.9%, respectively, demonstrating good operational efficiency.

Balance Sheet

The company maintains a balanced financial structure with an equity ratio of 39.7% in TTM, indicating a stable asset base funded by equity. The debt-to-equity ratio increased to 0.97, reflecting higher leverage, which could pose risks if not managed properly. However, return on equity improved to 18.0%, showcasing effective use of shareholder funds.

Cash Flow

Operating cash flow to net income ratio is 1.09 for TTM, indicating good cash generation relative to net income. Free cash flow decreased by 45.4% in TTM, which is a concern, but remains positive at $219 million. The free cash flow to net income ratio is 0.73, suggesting adequate but declining free cash flow coverage.

Breakdown
TTM	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement		Total Revenue
5.40B	5.31B	4.90B	4.63B	4.25B	3.46B
	Gross Profit
1.27B	1.25B	1.03B	939.81M	946.98M	711.00M
	EBIT
493.25M	488.50M	294.79M	325.90M	408.53M	288.28M
	EBITDA
589.26M	488.50M	456.45M	464.76M	502.74M	396.08M
	Net Income Common Stockholders
300.02M	306.91M	161.79M	203.83M	291.20M	214.51M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
108.06M	183.12M	65.41M	40.66M	135.06M	71.74M
	Total Assets
4.20B	4.13B	3.99B	3.99B	4.12B	2.02B
	Total Debt
1.62B	1.28B	1.43B	1.51B	1.71B	213.65M
	Net Debt
1.51B	1.09B	1.36B	1.47B	1.57B	141.92M
	Total Liabilities
2.53B	2.29B	2.32B	2.44B	2.64B	782.88M
	Stockholders Equity
1.67B	1.84B	1.67B	1.55B	1.48B	1.24B
Cash Flow		Free Cash Flow
219.04M	401.07M	223.65M	233.69M	480.76M	203.88M
	Operating Cash Flow
325.88M	515.26M	314.34M	289.84M	517.32M	244.59M
	Investing Cash Flow
-108.26M	-129.10M	-80.96M	-54.01M	-1.84B	-44.14M
	Financing Cash Flow
-180.48M	-275.65M	-250.80M	-248.27M	1.39B	-230.09M

Maximus Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 69.80
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MMS, the sentiment is Negative. The current price of 69.8 is below the 20-day moving average (MA) of 72.27, below the 50-day MA of 70.26, and below the 200-day MA of 75.99, indicating a bearish trend. The MACD of -0.18 indicates Positive momentum. The RSI at 43.27 is Neutral, neither overbought nor oversold. The STOCH value of 27.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MMS.

Maximus Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MMS	81 Outperform	$3.93B	13.88	17.36%	1.72%	5.29%	31.95%
UNF	77 Outperform	$3.29B	22.93	7.17%	0.76%	5.04%	31.69%
CBZ	74 Outperform	$3.76B	46.84	6.25%	―	32.27%	-40.50%
ARMK	71 Outperform	$10.50B	30.85	11.77%	1.05%	-3.47%	-45.03%
Sector *	66 Neutral	$4.47B	12.22	5.40%	3.65%	4.14%	-12.00%
ABM	61 Neutral	$2.80B	35.97	4.30%	2.36%	3.52%	-67.27%
FA	58 Neutral	$3.16B	549.40	-13.59%	―	37.97%	-499.29%

Maximus Corporate Events

Maximus Updates By-laws for Shareholder Proposals

On June 10, 2025, Maximus, Inc. amended its By-laws to enhance disclosure requirements for shareholders proposing director nominations or business at meetings. These changes include detailed disclosure of stock ownership, performance-related fees, and material relationships, as well as compliance certifications with applicable laws. The amendments also limit the number of board nominees a shareholder can propose, prohibit substitute nominations without notice, and require updates to shareholder information. Additionally, the By-laws now align with Virginia Stock Corporation Act provisions and include technical updates.

The most recent analyst rating on (MMS) stock is a Buy with a $90.00 price target. To see the full list of analyst forecasts on Maximus stock, see the MMS Stock Forecast page.